Efficacy of antimicrobial polymer coatings in an animal model of bacterial infection associated with foreign body implants

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 974-980

  Hart, Emily ^a,b   Azzopardi, Kristy ^a,b   Taing, Heng ^c   Graichen, Florian ^c   Jeffery, Justine ^c   Mayadunne, Roshan ^c   Wickramaratna, Malsha ^c   O'Shea, Mike ^c   Nijagal, Brunda ^d   Watkinson, Rebecca ^d   O'Leary, Stephen ^e   Finnin, Barrie ^d   Tait, Russell ^f,g   Robins Browne, Roy ^a,b,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c CSIRO   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^f BIONIC EAR INSTITUTE   (Australia)

^g Bionic Technologies Australia   (Australia)

Author keywords

Implant associated infections; Levofloxacin; Staphylococcus aureus

Indexed keywords

ALIPHATIC COMPOUND; ALIPHATIC POLYESTER POLYURETHANE; LEVOFLOXACIN; POLYCAPROLACTONE; POLYETHYLENE TEREPHTHALATE; POLYLACTIC ACID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; OFLOXACIN; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DISEASE ASSOCIATION; DRUG COATING; DRUG EFFICACY; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; FOREIGN BODY; MOUSE; NONHUMAN; PROSTHESIS INFECTION; STAPHYLOCOCCUS INFECTION; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG EFFECT; HUMAN; INFECTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; FOREIGN BODIES; HUMANS; MICE; MICE, INBRED BALB C; OFLOXACIN; POLYMERS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77953723684     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq057     Document Type: Article

References (22)

1. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001; 33: 1567-72.
2. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
3. Darouiche RO. Antimicrobial coating of devices for prevention of infection: principles and protection. Int J Artif Organs 2007; 30: 820-7.
4. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003; 36: 1284-9.
5. Castro C, Sanchez E, Delgado A et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Control Release 2003; 93: 341-54.
6. Pistos C, Tsantili-Kakoulidou A, Koupparis M. Investigation of the retention/pH profile of zwitterionic fluoroquinolones in reversed-phase and ion-interaction high performance liquid chromatography. J Pharm Biomed Anal 2005; 39: 438-43.
7. Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release 1998; 54: 167-75.
8. Kadurugamuwa JL, Sin L, Albert E et al. Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 2003; 71: 882-90.
9. International Organization for Standardization. Biological Evaluation of Medical Devices - Part 13: Identification and Quantification of Degradation Products from Polymeric Medical Devices, ISO 10993-13. Geneva: ISO, 1998.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A8. NCCLS, Wayne, PA, USA, 2003.
11. Zabramski JM, Whiting D, Darouiche RO et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003; 98: 725-30.
12. Chatzinikolaou I, Hanna H, Graviss L et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003; 24: 961-3.
13. Darouiche RO, Berger DH, Khardori N et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 2005; 242: 193-200.
14. Hanna H, Benjamin R, Chatzinikolaou I et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004; 22: 3163-71.
15. Raad I, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127: 267-74.
16. Sherertz RJ, Carruth WA, Hampton AA et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993; 167: 98-106.
17. Darouiche RO, Meade R, Mansouri M et al. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. J Heart Valve Dis 1998; 7: 639-46.
18. Darouiche RO, Mansouri MD, Zakarevicz D et al. In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg Am 2007; 89: 792-7.
19. Pitt CG, Jeffcoat AR, Zweidinger RA et al. Sustained drug delivery systems. I. The permeability of poly(1-caprolactone), poly(DL-lactic acid), and their copolymers. J Biomed Mater Res 1979; 13: 497-507.
20. Kranz H, Ubrich N, Maincent P et al. Physicomechanical properties of biodegradable poly(DL-lactide) and poly(DL-lactide-co-glycolide) films in the dry and wet states. J Pharm Sci 2000; 89: 1558-66.
21. Engelberg I, Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991; 12: 292-304.
22. Omelczuk MO, McGinity JW. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid). Pharm Res 1992; 9: 26-32.